Chromosomal imbalances in primary and metastatic melanomas: Over-representation of essential telomerase genes

Melanoma Research

Volumn 13, Issue 5, 2003, Pages 483-492

  Pirker, Christine ^a   Holzmann, Klaus ^a   Spiegl Kreinecker, Sabine ^a   Elbling, Leonilla ^a   Thallinger, Christiane ^a   Pehamberger, Hubert ^a   Micksche, Michael ^a   Berger, Walter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Comparative genomic hybridization; Cutaneous melanoma; Gene amplification; Telomerase genes

Indexed keywords

ISOENZYME; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CELL CULTURE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 17Q; CHROMOSOME 20P; CHROMOSOME 20Q; CHROMOSOME 4Q; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 7Q; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CHROMOSOME NOR; COMPARATIVE GENOMIC HYBRIDIZATION; EFFUSION; ENZYME REPRESSION; ESSENTIAL GENE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE LOCUS; GENE SEQUENCE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MALE; MELANOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SOUTHERN BLOTTING; TELOMERASE REVERSE TRANSCRIPTASE GENE; TELOMERASE RNA COMPONENT GENE;

ADULT; AGED; BLOTTING, SOUTHERN; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 5; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FEMALE; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MELANOMA; METAPHASE; MIDDLE AGED; NEOPLASM METASTASIS; NUCLEIC ACID HYBRIDIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0142025379     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200310000-00007     Document Type: Article

References (32)

1. Hall HI, Miller DR, Rogers JD, Bewerse B. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 1999; 40:35-42.
2. Satyamoorthy K, Herlyn M. Cellular and molecular biology of human melanoma. Cancer Biol Ther 2002; 1:14-17.
3. Walker GJ, Palmer JM, Walters MK, Hayward NK. A genetic model of melanoma tumorigenesis based on allelic losses. Genes Chromosomes Cancer 1995; 12:134-141.
4. Slominski A, Wortsman J, Carlson AJ, Matsuoka LY, Balch CM, Mihm MC. Malignant melanoma. Arch Pathol Lab Med 2001; 125:1295-1306.
5. Piepkorn M. Melanoma genetics: an update with focus on the CDKN2A(p16)/ARF tumor suppressors. J Am Acad Dermatol 2000; 42:705-722.
6. Keith NW, Evans JTR, Glasspool RM. Telomerase and cancer: time to move from a promising target to a clinical reality. J Pathol 2001; 195: 404-414.
7. Shay JW, Zou Y, Hiyama E, Wright WE. Telomerase and cancer. Hum Mol Genet 2001; 10:677-685.
8. Blasco MA. Telomerase beyond telomeres. Nat Rev Cancer 2002; 2: 627-633.
9. Cao Y, Li H, Deb S, Liu JP. TERT regulates cell survival independent of telomerase enzymatic activity. Oncogene 2002; 21:3130-3138.
10. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258:818-821.
11. Bastian BC, LeBoit PE, Hamm H, Brocker EB, Pinkel D. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 1998; 58:2170-2175.
12. Bastian BC, Kashani Sabet M, Hamm H, Godfrey T, Moore DH II, Brocker EB, et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 2000; 60:1968-1973.
13. Balazs M, Adam Z, Treszl A, Begany A, Hunyadi J, Adany R. Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytometry 2001; 46:222-232.
14. Berger W, Hauptmann E, Elbling L, Vetterlein M, Kokoschka EM, Micksche M. Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells. Int J Cancer 1997; 71:108-115.
15. Berger W, Elbling L, Minai Pour M, Vetterlein M, Pirker R, Kokoschka EM, Micksche M. Intrinsic MDR-1 gene and P-glycoprotein expression in human melanoma cell lines. Int J Cancer 1994; 59:717-723.
16. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 1992; 13: 718-725.
17. Ducrest AL, Szutorisz H, Lingner J, Nabholz M. Regulation of the human telomerase reverse transcriptase gene. Oncogene 2002; 21:541-552.
18. Villa R, Porta CD, Folini M, Daidone MG, Zaffaroni N. Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma. J Invest Dermatol 2001; 116:867-873.
19. Glaessl A, Bosserhoff AK, Buettner R, Hohenleutner U, Landthaler M, Stolz W. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas. Arch Dermatol Res 1999; 291:81-87.
20. Collins K, Mitchell JR. Telomerase in the human organism. Oncogene 2002; 21:564-579.
21. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996; 56:645-650.
22. Maser RS, DePinho RA. Connecting chromosomes, crisis, and cancer. Science 2002; 297:565-569.
23. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000; 406:641-645.
24. Greaves M. Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? Trends Genet 1996; 12:127-128.
25. Shay JW, Wright WE. The reactivation of telomerase activity in cancer progression. Trends Genet 1996; 12:129-131.
26. Zhang A, Zheng C, Lindvall C, Hou M, Ekedahl J, Lewensohn R, et al. Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res 2000; 60:6230-6235.
27. Zhang A, Zheng C, Hou M, Lindvall C, Wallin KL, Angstrom T, et al. Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas. Genes Chromosomes Cancer 2002; 34:269-275.
28. Baur JA, Zou Y, Shay JW, Wright WE. Telomere position effect in human cells. Science 2001; 292:2075-2077.
29. Dhaene K, Vancoillie G, Lambert J, Naeyaert JM, Van Marck E. Absence of telomerase activity and telomerase catalytic subunit mRNA in melanocyte cultures. Br J Cancer 2000; 82:1051-1057.
30. Saretzki G, Petersen S, Petersen I, Kolble K, von Zglinicki T. hTERT gene dosage correlates with telomerase activity in human lung cancer cell lines. Cancer Lett 2002; 176:81-91.
31. Sauter ER, Yeo UC, von Stemm A, Zhu W, Litwin S, Tichansky DS, et al. Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res 2002; 62:3200-3206.
32. Elenitoba Johnson KS. Complex regulation of telomerase activity: implications for cancer therapy. Am J Pathol 2001; 159:405-410.